IGF2BP1 and hepatocellular carcinoma: Mechanistically, WTAP-mediated m6A modification of circCMTM3 enhances its interaction with IGF2BP1, leading to increased PARK7 expression and stability, which suppresses ferroptosis in HCC (Chen S. et al., 2023).